Hidradenitis Suppurativa News

The FDA has accepted Yuflyma as an interchangeable biosimilar to adalimumab for the treatment of multiple chronic inflammatory diseases, Celltrion USA announced in a press release.

Researchers reported a shared genetic susceptibility of psoriasis and hidradenitis suppurativa, highlighting a need for patients with both conditions to receive unique disease management.

Newly released data from the phase 3 STOP-HS clinical trial program reveal positive results in hidradenitis suppurativa from povorcitinib treatment, Incyte announced in a press release.

ORLANDO — Outgoing American Academy of Dermatology President Seemal R. Desai, MD, FAAD, passed the torch to Susan C. Taylor, MD, FAAD, who said she will continue pushing efforts to unify the organization during “a time of great disruption.”

Glucagon-like peptide-1 receptor agonists, an increasingly popular class of weight loss medications, have been found to be associated with new onset acne in women, according to a research letter published in Journal of the American Academy of Dermatology.

New data showed that Bimzelx sustained disease control of hidradenitis suppurativa up to 2 years, UCB announced in a press release.

MIAMI BEACH, Fla. — Janus kinase inhibitors are an incredibly important, new tool that have exemplified both high efficacy and safety, according to a speaker at South Beach Symposium.

As the year comes to a close, Healio Dermatology has assembled this year’s top hidradenitis suppurativa articles.

An in-depth interview about the effects of the CMS’s 2025 physician fee schedule on patient access topped Healio Dermatology’s most-read articles of November, with FDA news also garnering attention.